China Tian Yuan Healthcare Group Limited (HK:0557)
:0557
Want to see HK:0557 full AI Analyst Report?
0557 Stock Chart & Stats
HK$0.70
-HK$0.10(-14.71%)
At close: 4:00 PM EST
HK$0.70
-HK$0.10(-14.71%)
Day’s Range― - ―
52-Week RangeHK$0.09 - HK$0.99
Previous CloseN/A
Volume26.00K
Average Volume (3M)3.33K
Market Cap
HK$271.31M
Enterprise ValueHK$282.29M
Total Cash (Recent Filing)HK$29.51M
Total Debt (Recent Filing)HK$38.72M
Price to Earnings (P/E)―
Beta-0.86
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding398,979,520
10 Day Avg. Volume1,000
30 Day Avg. Volume3,326
Financial Highlights & Ratios
PEG Ratio14.08
Price to Book (P/B)1.73
Price to Sales (P/S)14.56
P/FCF Ratio30.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative LeverageA low debt-to-equity ratio around 0.20–0.24 gives the company financial flexibility and lower fixed interest obligations. Over the medium term this reduces refinancing risk and preserves capacity to fund operations or strategic moves while revenue weakness is addressed, supporting solvency durability.
Improving Cash GenerationPositive operating and free cash flow across 2023–2025 indicates the business can generate cash despite accounting losses. That cash converts into liquidity for capex, working capital or restructuring, reducing reliance on external financing and improving survivability while management works on revenue recovery.
High Gross MarginsSustained gross margins above ~50% show the core service/product economics are favorable at the direct cost level. If overheads are restructured or revenue stabilizes, those gross margins provide a clear pathway to restore operating profitability and scalable margin improvement over the medium term.
Bears Say
Sharply Declining RevenueA multi-year revenue decline, including ~27% drop in 2025, erodes scale and market presence. Reduced top-line makes fixed costs harder to cover, weakens pricing power and lengthens time to profitability. Structural demand or competitive issues are likely drivers that require strategic change to reverse.
Persistent Operating LossesConsistent negative EBIT and EBITDA show core operations fail to cover operating expenses. Prolonged operating losses deplete reserves, constrain reinvestment and increase dependence on external funding. Without sustainable operating break-even, recovery remains uncertain and strategic options shrink.
Worsening Returns And Equity ErosionROE near -21% and declining equity indicate ongoing value destruction and weakening capital cushions. This reduces ability to absorb shocks, raises cost of new capital, and limits strategic investments. Structural equity erosion makes long-term recovery more difficult without external recapitalization.
China Tian Yuan Healthcare Group Limited News
0557 FAQ
What was China Tian Yuan Healthcare Group Limited’s price range in the past 12 months?
China Tian Yuan Healthcare Group Limited lowest stock price was HK$0.09 and its highest was HK$0.99 in the past 12 months.
What is China Tian Yuan Healthcare Group Limited’s market cap?
China Tian Yuan Healthcare Group Limited’s market cap is HK$271.31M.
When is China Tian Yuan Healthcare Group Limited’s upcoming earnings report date?
China Tian Yuan Healthcare Group Limited’s upcoming earnings report date is Aug 31, 2026 which is in 70 days.
How were China Tian Yuan Healthcare Group Limited’s earnings last quarter?
China Tian Yuan Healthcare Group Limited released its earnings results on Mar 30, 2026. The company reported -HK$0.078 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.078.
Is China Tian Yuan Healthcare Group Limited overvalued?
According to Wall Street analysts China Tian Yuan Healthcare Group Limited’s price is currently Overvalued.
Does China Tian Yuan Healthcare Group Limited pay dividends?
China Tian Yuan Healthcare Group Limited does not currently pay dividends.
What is China Tian Yuan Healthcare Group Limited’s EPS estimate?
China Tian Yuan Healthcare Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Tian Yuan Healthcare Group Limited have?
China Tian Yuan Healthcare Group Limited has 398,979,520 shares outstanding.
What happened to China Tian Yuan Healthcare Group Limited’s price movement after its last earnings report?
China Tian Yuan Healthcare Group Limited reported an EPS of -HK$0.078 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Tian Yuan Healthcare Group Limited?
Currently, no hedge funds are holding shares in HK:0557
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Tian Yuan Healthcare Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.93%
12-Months-Change
Fundamentals
Return on Equity
-33.69%
Trailing 12-Months
Asset Growth
-13.78%
Trailing 12-Months
Company Description
China Tian Yuan Healthcare Group Limited
China Tian Yuan Healthcare Group Limited functions as an investment holding enterprise, delivering a range of healthcare-focused services spanning Hong Kong, Korea, and the People's Republic of China. The company's business activities are categorized into Investment Holding, Healthcare, Money Lending and Related Business, and Hospitality divisions. In its Healthcare arm, it offers procurement, marketing, and management support to the medical sector, alongside providing plastic surgery procedures and trademark licensing. The Investment Holding segment is responsible for capital deployment in equity investments and publicly traded equity mutual funds. Its Money Lending and Related Business provides financial assistance through loans and acts as an intermediary connecting lenders and borrowers. Furthermore, the Hospitality division specializes in procurement services for the hotel industry. Established in 1990, the company was previously known as City e-Solutions Limited before rebranding to China Tian Yuan Healthcare Group Limited in November 2017. It is based in Wan Chai, Hong Kong, and operates as a subsidiary of Tian Yuan Manganese Limited.
Technical Analysis
Keck Seng Investments (Hong Kong)
―
Langham Hospitality Investments
―
Magnificent Hotel Investments Limited
―
Sino Hotels (Holdings) Ltd.
―
Regal Hotels International Holdings Limited
―